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TonEBP/NFAT5 promotes obesity and insulin
resistance by epigenetic suppression of white
adipose tissue beiging
Hwan Hee Lee1, Seung Min An1, Byeong Jin Ye1, Jun Ho Lee1, Eun Jin Yoo1, Gyu Won Jeong1, Hyun Je Kang1,
Assim A. Alfadda2, Sun Woo Lim3, Jiyoung Park 1, Whaseon Lee-Kwon1, Jae Bum Kim 4,
Soo Youn Choi 1 & Hyug Moo Kwon1
Tonicity-responsive enhancer binding protein (TonEBP or NFAT5) is a regulator of cellular
adaptation to hypertonicity, macrophage activation and T-cell development. Here we report
that TonEBP is an epigenetic regulator of thermogenesis and obesity. In mouse subcutaneous
adipocytes, TonEBP expression increases > 50-fold in response to high-fat diet (HFD) feeding.
Mice with TonEBP haplo-deﬁciency or adipocyte-speciﬁc TonEBP deﬁciency are resistant to
HFD-induced obesity and metabolic defects (hyperglycemia, hyperlipidemia, and hyper-
insulinemia). They also display increased oxygen consumption, resistance to hypothermia, and
beiging of subcutaneous fat tissues. TonEBP suppresses the promoter of β3-adrenoreceptor
gene, a critical regulator of lipolysis and thermogenesis, in ex vivo and cultured adipocytes.
This involves recruitment of DNMT1 DNA methylase and methylation of the promoter. In
human subcutaneous adipocytes TonEBP expression displays a correlation with body mass
index but an inverse correlation with β3-adrenoreceptor expression. Thus, TonEBP is an
attractive therapeutic target for obesity, insulin resistance, and hyperlipidemia.
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Energy balance is an important factor in the pathogenesis ofmetabolic disease. If energy intake exceeds energy expen-diture, weight gain and ultimately obesity result. Excess
energy is stored as lipids in adipose tissue, but unfettered
expansion of adipose tissue can result in a pathological condition
characterized by local hypoxia, which leads to insulin resistance,
impaired thermogenic activity, and chronic inﬂammation1,2.
Adipose tissue is also capable of transforming chemical energy
into heat, thereby opposing excessive fat accumulation, through
the activity of specialized thermogenic adipocytes. The classical
brown adipocytes in brown adipose tissue constitutively express
thermogenic genes. In addition, brown-like adipocytes or beige
cells are also present in white adipose tissue. Thermogenesis can
be induced in these cells in response to a variety of activators3.
Activation of the thermogenic gene program in brown or beige
adipocytes increases systemic energy expenditure and can ame-
liorate or prevent the development of obesity-associated meta-
bolic disorders as a result. Thus, efforts aimed at gaining a deeper
understanding of the regulation of energy storage, mobilization,
and use by adipocytes may lead to the identiﬁcation of therapy for
metabolic disease4.
Tonicity-responsive enhancer-binding protein (TonEBP), also
known as nuclear factor of activated T cells 5 (NFAT5), belongs to
the Rel family of transcriptional factors, which includes nuclear
factor κB and NFAT1–45,6. TonEBP was initially identiﬁed as the
central regulator of cellular response to hypertonic stress5,7,8. Recent
studies reveal that TonEBP is involved in the M1 activation of
macrophages, because it promotes the expression of pro-
inﬂammatory genes and suppresses anti-inﬂammatory cytokines
in response to toll-like receptor-4 activation9–11 or hyperglycemia12.
TonEBP haplo-deﬁcient mice show lower levels of inﬂammation
and are resistant to inﬂammatory and autoimmune diseases,
including sepsis10, rheumatoid arthritis13,14, atherosclerosis15,
encephalomyelitis16, and diabetic nephropathy12. Interestingly,
TonEBP suppresses peroxisome proliferator-activated receptor-2
(PPARγ2) expression during adipocyte differentiation, suggesting
that TonEBP is involved in controlling adipogenesis17,18.
MicroRNAs (miRs), short noncoding RNAs, block translation
or induce degradation of the target mRNAs by base-pairing to
complementary sequences19. Recently, the associations between
TonEBP and miRs have been reported in cancer and diabetes20–22,
but there has been no report on adipose tissues. Here, we ﬁnd that
elevated expression of TonEBP due to downregulation of miR-30
in adipocytes leads to the development of obesity and insulin
resistance, whereas its ablation enhances adipocyte beiging and
prevents ectopic deposition of triglycerides.
Results
Adipose TonEBP expression is elevated in obesity. TonEBP is
widely expressed in many tissues. Interestingly, TonEBP mRNA
and protein expression was dramatically escalated in inguinal
white adipose tissue (iWAT), and to a lesser extent in epididymal
white adipose tissue (eWAT), of mice fed with a high-fat diet
(HFD; 60% energy as fat) compared with animals fed with a chow
diet (CD; 10% energy as fat) (Fig. 1a, b). Likewise, TonEBP
mRNA expression was elevated in iWAT from 10-week-old db/db
(Leprdb/db) obese mice compared with their lean db/+ littermates
(Supplementary Fig. 1a). In addition, the HFD-fed mice exhibited
lower mRNA expression of thermogenic genes—PPARγ coacti-
vator 1α (PGC1-α), Dio2, CPT1α, Cidea, PPARα, and β3-
adrenergic receptor (Adrb3)—and beiging markers—UCP-1,
CD137, and TMEM26—in iWAT (Supplementary Fig. 1b and c).
In a group of human subjects, TonEBP mRNA expression in
subcutaneous adipocytes correlated positively with body mass
index (BMI) (Fig. 1c). Taken together, these data suggest that
TonEBP expression in iWAT is associated with obesity and
suppression of thermogenic gene expression.
The microRNA-30 (miR-30) family is a potent regulator of
thermogenesis in adipocytes23, and miR-30 expression is reduced
in obese mice24. Using prediction algorithms in TargetScan
Mouse 6.2 (www.targetscan.org), we found that TonEBP mRNA
was a potential target of miR-30 with two binding sites for miR-
30b and miR-30c in its 3′UTR (Supplementary Fig. 1d). TonEBP
mRNA and protein expression was signiﬁcantly reduced in 3T3-
L1 adipocytes transfected with miR-30b or miR-30c mimic
(Fig. 1d, e). Consistent with this, miR-30b or miR-30c mimic
enhanced mRNA expression of thermogenic genes (Supplemen-
tary Fig. 1e). To identify direct binding to TonEBP 3′UTR of
miR-30b and miR-30c, we constructed luciferase vector
psiCHECK-2 fused with two putative binding sites on TonEBP
3′UTR region. The luciferase activity was reduced by transfection
with miR-30b or miR-30c mimic (Supplementary Fig. 1f),
indicating direct binding of miR-30b and miR-30c to the 3′
UTR of TonEBP. These data demonstrate that the reduced
expression of miR-30b and miR-30c in obesity contributes to the
escalation of TonEBP expression and the suppression of
thermogenic genes. Thus, miR-30 promotes thermogenesis and
beiging via suppression of two transcriptional regulators—
TonEBP and RIP14023.
TonEBP haplo-deﬁcient mice are resistant to obesity. To
investigate the physiological role of TonEBP, TonEBP haplo-
deﬁcient mice (TonEBP+/Δ), and their wild-type littermates
(TonEBP+/+) were fed with either a CD or HFD starting at
8 weeks of age. When fed with the CD, the two groups of animals
showed similar weight gain (Fig. 1f). On the other hand, when fed
with the HFD, the TonEBP haplo-deﬁcient animals were resistant
to weight gain (Fig. 1f, g), despite comparable food intake (Sup-
plementary Fig. 2a). Whole-body echo MRI analysis was per-
formed to analyze fat content. The lower body mass of TonEBP
haplo-deﬁcient mice was accounted for largely by a reduction in
fat mass, without alterations in body length or lean body mass
(Fig. 1h). Examination of dissected fat tissues conﬁrmed that
epididymal, inguinal, and dorsal fat pads were smaller in these
animals (Fig. 1i). Likewise, TonEBP haplo-deﬁciency on the
Leprdb/db background was protected against weight gain and
adiposity (Supplementary Fig. 2b, c). Thus, TonEBP deﬁciency
resists obesity by interfering with fat expansion.
Adipocyte TonEBP suppresses thermogenesis and beiging of
WAT. Reduction in adipose tissue mass without alterations in
food intake (Fig. 1i and Supplementary Fig. 2a) suggested an
increase in energy expenditure by the TonEBP haplo-deﬁcient
mice. Analyses of these animals by indirect calorimetry revealed
higher oxygen consumption rate (VO2) and carbon dioxide
production rate (VCO2) (Fig. 2a, b), with no changes in
respiratory exchange ratio (RER) (Supplementary Fig. 3a). Con-
sistent with the higher VO2, these animals generated more heat
(Fig. 2c) and had an ~0.6 °C higher body temperature (Fig. 2d). In
addition, the body temperature remained higher when exposed to
cold (4 °C) in CD- (Fig. 2e) and HFD-fed mice (Supplementary
Fig. 3b), suggesting more efﬁcient adaptive thermogenesis.
Reduced thermogenesis is a characteristic feature of obesity in
humans and mice25. We asked whether TonEBP affected
thermogenesis and browning of adipocytes. The TonEBP haplo-
deﬁcient mice had higher expression of thermogenic genes
(Fig. 2f), and beige marker genes in iWAT (Fig. 2g), but not in
BAT (Supplementary Fig. 3c). This pattern of higher expression
was largely maintained after the animals were exposed to cold
(Fig. 2h and Supplementary Fig. 3d). Histological and
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immunohistochemical analysis of iWAT revealed enhanced
features of beiging WAT in these animals—multilocular lipid
droplets and higher expression of UCP-1 (Fig. 2i).
Next, we examined adipocytes in vitro. Adipocytes differen-
tiated from stromal vascular fractions (SVF) of the TonEBP
haplo-deﬁcient animals showed elevated expression of thermo-
genic genes, hormone-sensitive lipase (HSL), and beige marker
genes (Fig. 2j, k and Supplementary Fig. 4a). In addition, TonEBP
knockdown (Supplementary Fig. 4b) enhanced, while adenovirus-
mediated overexpression of TonEBP reduced the basal and
isoproterenol-stimulated expression of these genes in differen-
tiated 3T3-L1 cells (Supplementary Fig. 4c). These ﬁndings
demonstrate that TonEBP suppresses energy expenditure by
blocking thermogenesis and beiging of WAT.
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Fig. 1 Adipocyte TonEBP expression is elevated in obesity and TonEBP-deﬁcient mice resist obesity. a TonEBP mRNA levels in iWAT, eWAT, BAT,
muscle, and liver from C57BL/6 J mice fed with CD (chow diet, n= 5) or HFD (high-fat diet, n= 7) for 16 weeks. b Immunoblots (top) and
quantiﬁcation of protein levels (bottom) of TonEBP and Hsc70 in iWAT and eWAT (CD, n= 4; HFD, n= 6). c Correlation of TONEBP mRNA levels in
human subcutaneous adipocytes and BMI (n= 15). TonEBP mRNA (d) and representative immunoblots (e, top) and quantiﬁcation of protein levels
(e, bottom) in 3T3-L1 adipocytes transfected with miR-negative control (NC), miR-30b (30b), or miR-30c (30c) (n= 4). f–i TonEBP+/Δ mice (+ /Δ)
and their TonEBP+/+ littermates (+/+) were fed with CD or HFD as indicated. f Changes in body weight after a switch to HFD (CD+/+, n= 7;
CD+ /Δ, n= 7; HFD+/+, n= 13; HFD+/Δ, n= 11). g Representative images of animals fed with HFD. h Body weight, height, fat mass, and lean mass
(n= 8). i Representative images (top) and weight (bottom) of fat pads from HFD-fed animals (n= 4). n represents number of biologically
independent samples (a–c, i) or animals (f–h) or independent experiments with triplicate (d, e). All data are presented as mean+ s.e.m. (a, b, f, h, i)
or+ s.d. (d, e). AU, arbitrary unit. The p-values are determined by unpaired t-test (a,b, h, i) or one-way ANOVA (d–f). *p < 0.05 vs. CD (a), NC (d), or
+/+ (f, h, i). Source data are provided as a Source Data ﬁle
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TonEBP haplo-deﬁcient mice resist obesity-induced metabolic
dysfunction. We next assessed glucose homeostasis and insulin
sensitivity in the HFD-fed animals. The TonEBP haplo-deﬁcient
mice maintained lower fasting glucose levels than their WT lit-
termates from week 1 to 16 of HFD feeding (Fig. 3a) and showed
improved glucose tolerance and insulin sensitivity (Fig. 3b). After
16 weeks of HFD feeding, the TonEBP haplo-deﬁcient mice
showed the lack of increase in circulating insulin levels seen in
their WT littermates (Fig. 3c). Likewise, Leprdb/db obese mice with
TonEBP haplo-deﬁciency had lower blood glucose levels than
their WT littermates (Supplementary Fig. 5a). In order to assess
insulin signaling directly, Akt phosphorylation in response to
insulin administration was examined in the liver and
eWAT, where HFD-induced inﬂammation causes local insulin
resistance and changes in adipokine expression26. Phosphoryla-
tion was signiﬁcantly higher in eWAT and liver of the TonEBP
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Fig. 2 TonEBP deﬁciency promotes energy expenditure and beiging of WAT. HFD-fed animals were analyzed by indirect calorimetry to obtain VO2 (a),
VCO2 (b), and heat production (c) (n= 4). Rectal temperature (temp.) measured in CD-fed animals at room temperature (n= 8) (d) and after exposure to
cold up to 6 h as indicated (4 °C) (n= 6) (e). f, g mRNA abundance of thermogenic genes (f) and beiging marker genes (g) in iWAT of HFD-fed animals
(n= 5). h mRNA abundance of thermogenic genes (left, n= 10) and immunoblots of UCP-1 and Hsc70 (right, n= 3) in iWAT of CD-fed animals exposed
to cold (4 °C). i Representative images of iWAT sections stained with H&E and UCP-1 antibody from CD-fed animals exposed to cold (4 °C). Scale bars,
100 μm. j, k Thermogenic gene (j) and beige marker (k) mRNA abundance in beige adipocytes differentiated from the stromal vascular cells of iWAT (n=
4). n represents number of biologically independent animals (a–e) or samples (f–k). a–h, j, k All data are presented as mean+ s.e.m. AU arbitrary unit. The
p-values are determined by unpaired t-test (d, f–k) or one-way ANOVA (a–c, e). *p < 0.05 vs. +/+. Source data are provided as a Source Data ﬁle
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haplo-deﬁcient animals, demonstrating more efﬁcient insulin
signaling (Fig. 3d).
In addition to its role in lipid storage, adipose tissue also
functions as an endocrine organ secreting a large number of
adipokines, which can modify systemic glucose homeostasis and
insulin sensitivity. We found that circulating levels of the
antidiabetic adipokine adiponectin27 were signiﬁcantly higher in
the TonEBP haplo-deﬁcient mice on the HFD (Fig. 3e, left).
Consistent with this, adiponectin mRNA expression in eWAT
was higher in these animals (Fig. 3e, right). On the other hand,
levels of serum adipokine leptin28 were lower in these mice
(Fig. 3f, left) as were leptin mRNA levels in eWAT (Fig. 3f, right).
These data indicate that TonEBP deﬁciency led to an adipokine
proﬁle favoring insulin sensitivity.
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Histological analysis revealed signiﬁcantly lower lipid accumula-
tion in brown adipose tissues and smaller adipocyte size in iWAT
from the HFD-fed TonEBP haplo-deﬁcient mice (Fig. 3g), indicat-
ing that TonEBP deﬁciency leads to a healthier adipocyte
morphology as a result of lower triglyceride accumulation, possibly
due to an increased rate of lipolysis. In addition, eWAT of these
animals contained signiﬁcantly fewer crown-like structures (Fig. 3h),
lower macrophage inﬁltration (Fig. 3i), and lower expression of the
inﬂammatory cytokine tumor necrosis factor α (TNFα) (Fig. 3j),
indicating reduced inﬂammation. Obesity-induced inﬂammation is
known to suppress genes involved in lipid metabolism in eWAT29.
Suppression of genes involved in lipid metabolism was indeed
observed in eWAT in response to HFD feeding (Supplementary
Fig. 5b), but expression of these genes was restored in the TonEBP
haplo-deﬁcient animals (Supplementary Fig. 5c), consistent with the
reduced inﬂammation.
Chronic exposure of mice to HFD causes hepatic steatosis and
increased liver mass30,31. As expected, HFD-fed mice showed an
enlarged liver (Fig. 3k) with large lipid droplets (Fig. 3l), and
elevated circulating levels of alanine aminotransferase (ALT)
(Fig. 3m), triglycerides, LDL, and cholesterol, but not free fatty
acid (FFA) (Fig. 3n). All of these changes were dramatically
tempered in the TonEBP haplo-deﬁcient animals. In the obese
Leprdb/db mice, TonEBP haplo-deﬁciency was associated with a
smaller liver (Supplementary Fig. 5d), suggesting similar changes
in this model of obesity. Collectively, the data in Fig. 3
demonstrate that TonEBP mediates the detrimental effects of
obesity, such as insulin resistance, altered serum adipokine
proﬁle, dyslipidemia, and hepatic steatosis.
TonEBP suppresses Adrb3 gene expression by DNA methyla-
tion. Stimulation of Adrb3 signaling by sympathetic activation
increases thermogenesis and HSL-mediated lipolysis, leading to
reduced fat mass32. In a group of human subjects, we found that
there was an inverse relationship between mRNA levels of Adrb3
vs. TonEBP in subcutaneous adipocytes (Fig. 4a), suggesting that
TonEBP suppressed Adrb3 expression. In mice, Adrb3 mRNA
levels in iWAT were suppressed by HFD and this suppression was
reversed in the TonEBP haplo-deﬁciency (Fig. 4b). When these
animals were exposed to cold, Adrb3 expression in iWAT was
higher (Fig. 4c). Higher Adrb3 mRNA (Fig. 4d) and protein
(Supplementary Fig. 4a) expression were also observed in primary
adipocytes differentiated from SVF of the TonEBP haplo-
deﬁcient animals. The same was observed in both basal and
isoproterenol-stimulated, TonEBP-knocked-down 3T3-L1 cells
(Supplementary Fig. 6a), which was reversed when TonEBP was
overexpressed (Supplementary Fig. 6b). These data demonstrate
that TonEBP suppresses Adrb3 expression in adipocytes.
We asked whether the enhanced expression of Adrb3 in response
to TonEBP haplo-deﬁciency was responsible for the elevated
expression of thermogenic genes (Fig. 2f, g) and activation of
downstream signaling p-CREB (Supplementary Fig. 4a) and cAMP
level (Supplementary Fig. 6c). The mRNA levels of thermogenic
genes were elevated by TonEBP knockdown, while they were reduced
by Adrb3 knockdown (Fig. 4e). Notably, the enhancement of mRNA
expression by TonEBP knockdown was almost completely abolished
by TonEBP/Adrb3 double knockdown (Fig. 4e). Also, TonEBP
deﬁciency promotes thermogenic gene expression upon treatment
with CL316,243 (Adrb3 speciﬁc agonist) (Supplementary Fig. 6d)
suggesting Adrb3 dependence. These data demonstrate that TonEBP
suppresses thermogenic genes via downregulation of Adrb3 in
adipocytes.
We next investigated molecular basis of the TonEBP-mediated
Adrb3 gene suppression. First, we constructed a pGL3 luciferase
reporter vector by inserting a 6-kb promoter sequence from the
mouse Adrb3 gene (Fig. 4f). TonEBP knockdown stimulated the
Adrb3 promoter-driven luciferase expression in 3T3-L1 adipo-
cytes (Fig. 4g). Because the mouse Adrb3 promoter contains one
putative TonE (TonEBP binding sequence) (Fig. 4f), we
investigated whether TonEBP bound to the TonE using
electrophoretic mobility shift assay, and found that it did
(Supplementary Fig. 6e). To conﬁrm this interaction in situ, we
performed chromatin immunoprecipitation (ChIP). Fragments of
the Adrb3 promoter containing the TonE were precipitated by
TonEBP antibody, and this was reduced by TonEBP deﬁciency in
3T3-L1 cells (Fig. 4h) and primary adipocytes differentiated from
SVF (Supplementary Fig. 6f) demonstrating that TonEBP bound
to the region on the chromatin.
To investigate whether the stimulation of the Adrb3 promoter
activity in response to TonEBP knockdown was dependent on the
TonE in the promoter, we constructed a TonE-deleted Adrb3
promoter vector. The deletion mutant (ΔTonE) showed enhanced
transcriptional activity, which was not affected by TonEBP
knockdown (Fig. 4i), conﬁrming functionality of the TonE on
Adrb3 expression. Next, we examined chromatin accessibility in
the promoter region by analyzing sensitivity to micrococcal
nuclease (MNase). Chromatin accessibility was enhanced by
TonEBP knockdown at both the TonEBP binding region (A in
Fig. 4f) and two regions near the transcription start site (TSS, B
and C) (Fig. 4j). In addition, recruitment of RNA polymerase II to
the Adrb3 promoter was also stimulated by TonEBP knockdown
(Supplementary Fig. 7a) demonstrating that TonEBP binding to
the TonE site led to a blockage of accessibility to chromatin
around the transcription start site.
To understand molecular mechanism for chromatin remodel-
ing, we investigated epigenetic changes in response to TonEBP
deﬁciency. Monomethylation (H3K4me1) and trimethylation of
H3K4 (H3K4me3) and acetylation of H3K27 (H3K27ac) were
elevated, while trimethylation of H3K27 (H3K27me3) was
reduced by TonEBP knockdown at both the TonEBP binding
(A) region and region near TSS (B) of the Adrb3 promoter
consistent with activation of transcription (Fig. 4k). On the other
hand, these epigenetic marks at the GAPDH promoter were not
changed by TonEBP knockdown (Supplementary Fig. 7b). Mice
with TonEBP haplo-deﬁciency also showed similar epigenetic
changes at the Adrb3 promoter (Supplementary Fig. 7c).
Since DNA methylation was associated with insulin resistance
and thermogenic gene regulation33,34 and could regulate histone
modiﬁcations35–37, we analyzed DNA methylation in CpG sites in
the A, B, and C regions on the Adrb3 promoter (Fig. 4f) using
bisulﬁte sequencing (see Supplementary Fig. 8a). We found that
basal levels of DNA methylation were much higher in 3T3-L1
cells compared to iWAT and primary adipocytes (Fig. 4l,
Supplementary Fig. 8b and c). Consistent with this, we also
found that Adrb3 mRNA expression is 50–100 times higher in
iWAT and primary adipocytes (Supplementary Fig. 8d) indicat-
ing that 3T3-L1 cells had much more of ﬁbroblastic character-
istics. TonEBP deﬁciency in 3T3-L1 reduced DNA methylation of
the A, B, and C regions in 3T3-L1 adipocytes (Fig. 4l). TonEBP
deﬁciency also reduced DNA methylation of the B and C regions
of mouse iWAT and primary adipocytes differentiated from SVF
(Supplementary Fig. 8b, c). These results demonstrate that
TonEBP promotes DNA methylation of the Adrb3 promoter in
adipocytes of mice.
We found that in human subcutaneous adipocytes DNA
methylation of the Adrb3 promoter correlated negatively with
Adrb3 mRNA expression (Supplementary Fig. 8e), while
correlated positively with BMI (Supplementary Fig. 8f). These
data suggest that TonEBP may promote DNA methylation of the
Adrb3 promoter also in human adipocytes in view of the inverse
relationship between mRNA levels of Adrb3 vs. TonEBP (Fig. 4a).
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DNMT1 inhibition enhances Adrb3 expression and beiging of
WAT. Among the known DNA methyltransferases, DNMT1
promotes insulin resistance by mediating DNA methylation in
HFD-induced obese mice38. ChIP analysis showed that adipocyte
DNMT1 was recruited to the Adrb3 promoter in a TonEBP-
dependent manner in 3T3-L1 cells and primary adipocytes
(Fig. 4m and Supplementary Fig. 9a). In addition, co-
immunoprecipitation experiments showed that TonEBP and
DNMT1 interacted with each other (Fig. 4n). This interaction
appeared to take place in the Adrb3 promoter region because
binding of both TonEBP and DNMT1 to the promoter was
TonEBP-dependent in the A region (Supplementary Fig. 9b, c).
The same interaction was also observed in the B and C regions
suggesting that TonEBP–DNMT1 complex bound to the A region
made also contacts with the B and C regions. These ﬁndings
suggest that TonEBP is responsible for the recruitment of
DNMT1 to the Adrb3 promoter leading to DNA methylation and
suppression of the promoter.
To elucidate the potential role of DNA methylation in WAT
beiging, we used a DNMT inhibitor, RG108. Treatment of
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adipocytes with RG108 enhanced UCP-1 and Adrb3 expression
in a dose-dependent manner, without affecting expression of
TonEBP (Fig. 5a). When mice were treated with RG108 (12 mg/
kg intraperitoneally every 2 days), they resisted HFD-induced
gain in body mass (Fig. 5b, c), fat mass (Fig. 5c, d), and rise in
fasting glucose (Fig. 5e). The RG108-injected mice displayed
higher energy expenditure (Fig. 5f–h), resistance to cold (Fig. 5i),
and enhanced beiging of WAT (Fig. 5j, k). Since there are three
isoforms of DNMT—DNMT1, DNMT3a, and DNMT3b—we
asked which isoform was responsible for the effects of RG108.
When each isoform was individually knocked down using speciﬁc
siRNA, knockdown of DNMT1 led to elevated expression of
UCP-1 and Adrb3, while knockdown of other isoforms did not
(Fig. 5l). UCP-1 mRNA expression was not further elevated by
TonEBP/DNMT1 double knockdown (Supplementary Fig. 9d)
indicating that TonEBP and DNMT1 were in the same pathway.
In addition, activity of the Adrb3 promoter (WT) was enhanced
by DNMT1 knockdown (Fig. 5m, left), but that of the ΔTonE
mutant promoter (Fig. 4i) was not (Fig. 5m, right). These data are
consistent with the TonEBP-dependent recruitment of DNMT1
to the Adrb3 promoter described above (Fig. 4m). Thus,
TonEBP–DNMT1 complex (Fig. 4n) on the Adrb3 promoter
suppresses the promoter by DNA methylation.
Adipocyte-speciﬁc TonEBP deﬁciency displays phenotypes
similar to the TonEBP haplo-deﬁciency. In order to directly
evaluate the role of TonEBP in adipocytes, we generated
adipocyte-speciﬁc TonEBP knockout mice (AKO) using the Cre-
lox system (TonEBPﬂ/ﬂ; adiponectin promoter-driven Cre). As
controls, ﬂoxed TonEBP mice that did not express Cre recom-
binase were used (TonEBP ﬂ/ﬂ; WT). AKO mice and their WT
littermates were fed HFD for up to 12 weeks, starting at 8 weeks
of age. The AKO mice were resistant to the development of
obesity and showed lower fasting glucose levels than the WT mice
despite no differences in food intake (Fig. 6a). In addition, the
AKO mice demonstrated higher O2 consumption and CO2 pro-
duction rates (Fig. 6b, c) without changes in RER (Supplementary
Fig. 10a) and generated more heat (Fig. 6d), along with higher
body temperature than the WT animals (Fig. 6e and Supple-
mentary Fig. 10b) demonstrating higher energy expenditure. In
addition, they exhibited improved glucose and insulin tolerance
indicating higher insulin sensitivity (Supplementary Fig. 10c).
These mice also showed higher mRNA expression of Adrb3 and
thermogenic genes and beiging phenotype in iWAT with multi-
locular lipid droplet, similar to the haplo-deﬁcient mice, when
either HFD-fed (Fig. 6f) or cold-exposed (Fig. 6g, h). These data
further conﬁrm that adipocyte TonEBP suppresses thermogenesis
and beiging of WAT.
Discussion
We previously reported that TonEBP inhibited adipocyte differ-
entiation by suppressing PPARγ2 expression17 consistent with
the low TonEBP expression in mature adipocytes. Here we dis-
cover that TonEBP expression in subcutaneous adipocytes is
dramatically escalated in response to high calorie intake in two
different mouse models of obesity, and obese humans. This ele-
vation of TonEBP expression is mediated in part by a fall in miR-
30 expression. TonEBP binds to its cognate DNA sequence in the
Adrb3 promoter and recruits DNMT1 DNA methylase (Fig. 6h).
Ensuing DNA methylation of the promoter leads to diminished
Adrb3 expression and blockade of thermogenesis and lipolysis or
beiging, which in turn facilitates obesity and associated patholo-
gical states such as insulin resistance and dyslipidemia. Thus,
TonEBP is a newly recognized molecular regulator, which is
activated by the stress of excess calorie. Of note, relatively modest
inhibition of TonEBP, i.e., TonEBP haplo-deﬁciency, is highly
effective in preventing the pathological effects of TonEBP. As
such, it is an attractive therapeutic target for obesity and asso-
ciated diseases.
Inhibition of DNA methylation promotes adipogenesis34 and
improves insulin resistance33 in obese mice much like TonEBP
deﬁciency described here. In order to further explore the function of
the TonEBP–DNMT1 pathway in adipocytes, we analyzed expres-
sion of a panel of adipocyte physiology-related genes in 3T3-L1 cells
after separate knockdown of TonEBP and DNMT1 (Supplementary
Fig. 11). The results indicate that more than 60% of the genes are
regulated by the TonEBP–DNMT1 pathway suggesting that many
aspects of adipocyte physiology are potentially affected by the
pathway in addition to beiging and thermogenesis.
In mice and humans, Adrb3 stimulation increases thermo-
genesis, fat oxidation and lipolysis39–42. Adrb3 agonists also exert
potent anti-diabetic effects by improving insulin sensitivity in
mouse models of type 2 diabetes39,43. Moreover, in humans
Adrb3 stimulation induces thermogenesis with beneﬁcial meta-
bolic effects44. In adult humans, on the other hand, white adipose
tissue is characterized by a low expression of the Adrb345. This
limitation may explain the lack of efﬁcacy by Adrb3 agonists in
clinical trials46. Therefore, boosting the Adrb3 expression by
means of TonEBP inhibition offers distinctive opportunity in
therapeutic approach for obesity and metabolic diseases.
TonEBP was originally identiﬁed as a DNA binding transcrip-
tional enhancer5. It is clear now that this function applies mostly to
genes stimulated by hypertonicity such as aldose reductase or the
sodium/myo-inositol cotransporter. In macrophages, TonEBP sti-
mulates a host of pro-inﬂammatory genes as a transcription
cofactor for histone acetylation of the promoters without DNA
binding10. Likewise, in adipocytes and macrophages, TonEBP
Fig. 4 TonEBP suppresses Adrb3 gene expression. a Correlation of TonEBP mRNA with Adrb3 mRNA in human subcutaneous adipocytes (n= 15). b Adrb3
mRNA levels in iWAT from animals fed with a CD or HFD (CD, n= 5; HFD, n= 13). c Adrb3 immunostaining of iWAT from animals exposed to cold (4 °C).
Scale bars, 100 μm. d Adrb3 mRNA abundance in primary adipocytes (n= 4). e mRNA abundance of thermogenic genes in 3T3-L1 adipocytes transfected
with various siRNA’s as indicated (n= 4). f Schematic representation of the mouse Adrb3 gene promoter including the TonEBP binding site (TonE). A–C
indicate regions for bisulﬁte sequencing (n= 4). g 3T3-L1 adipocytes were transfected with siRNA followed by an Adrb3 promoter-luciferase reporter
construct. Luciferase was measured (n= 4). h TonEBP binding to the TonE (A region) of the Adrb3 promoter in 3T3-L1 adipocytes (n= 4). i The Adrb3
promoter-luciferase reporter described above (WT) and a mutant reporter where TonE was removed (ΔTonE) were analyzed in 3T3-L1 adipocytes (n= 4).
Chromatin accessibility of A, B, C, and D regions (see f) (j), and ChIP assay for H3K4me1, H3K4me3, H3K27ac, H3K27me3 and normal rabbit IgG (k) for A
and B regions, on the Adrb3 promoter region of 3T3-L1 adipocytes (n= 4). l DNA methylation analysis of the Adrb3 promoter using bisulﬁte sequencing in
3T3-L1 adipocytes. Left: bacterial clones without (open circles) or with methylation (solid circles) from representative experiments are shown. Right: % of
DNA methylation, mean+ s.d. (n= 4). m ChIP assay for DNMT1 on the Adrb3 promoter in 3T3-L1 adipocytes (n= 4). n Co-immunoprecipitation analyses
of TonEBP and DNMT1 in 3T3-L1 adipocytes. n represents number of biologically independent samples (a, b, d) or independent experiments with triplicate
(e, g–m). All data are presented as mean+ s.e.m. (b, d) or+ s.d. (e, g–m). AU arbitrary unit. The p-values are determined by unpaired t-test (d, j–l) or one-
way ANOVA (b, e, g, h, m). #p < 0.05 vs. CD (a, b), scr siRNA (e), empty vector (g), anti-rabbit serum (h), WT (i), or anti-rabbit IgG (m). *p < 0.05 vs.
+/+ (a–d), TonEBP siRNA (e), or scr siRNA (g–m). Source data are provided as a Source Data ﬁle
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suppresses transcription of PPARγ2 by mediating histone methy-
lation of its promoter region without DNA binding17. Here we add
transcriptional suppressor function of TonEBP that involves DNA
binding and DNA methylation. When TonEBP is knocked down in
various cultured cells, typically over 500 genes show changes in
mRNA expression in such a way that half of them increase, while
the other half decrease13. Such pleiotropic functions of TonEBP—
both transcriptional stimulation and transcriptional suppression
—are consistent with its bidirection regulation of many genes.
In macrophages TonEBP is a critical regulator of M1 polar-
ization, and TonEBP haplo-deﬁcient animals display a dramati-
cally reduced inﬂammation in settings of various inﬂammatory
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diseases including atherosclerosis15, rheumatoid arthritis13,14, and
diabetic nephropathy12 in association with reduced macrophage
activity. Since these diseases are also associated with obesity,
insulin resistance, and dyslipidemia47, TonEBP inhibition would
provide a multipronged therapeutic approach to a host of com-
plicated metabolic and inﬂammatory diseases.
Methods
Mice. All the methods involving live mice were carried out in accordance with the
approved guidelines. All experimental protocols were approved by Institutional
Animal Care and Use Committee of the Ulsan National Institute of Science and
Technology (UNISTACUC-12-15-A).
All studies used male C57BL/6 J background mice. TonEBP haplo-deﬁcient
mice (TonEBP+ /Δ) were described previously5. Mice carrying the loxP-targeted
TonEBP gene (TonEBPﬂ/ﬂ) were provided by Dr Neuhofer48. Leptin receptor
mutant db/db (Leprdb/db) mice and Adiponectin-Cre transgenic mice (AQ-cre) were
obtained from The Jackson Laboratory (USA). TonEBPﬂ/ﬂ mice were bred with
AQ-Cre knock-in mice to generate TonEBPﬂ/ﬂ AQ-Cre mice.
For obese mice model, mice at 8 weeks age were fed either a CD (10% fat as
kcal, Research Diets, NJ, USA) or HFD (60% fat as kcal, Research Diets) during
16 weeks. Mice were intraperitoneally injected with RG108 (Cayman, MI, USA) at
12 mg/kg every 2 days.
Cells and reagents. Pre-adipocyte cell line 3T3-L1 (CR-173) and HEK293 (CRL-
1573) cells from American Type Culture Collection were cultured in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM) containing 10% fetal bovine serum (Thermo
Fisher Scientiﬁc Inc., MA, USA) and penicillin/streptomycin (100 U/ml and 100
μg/ml; GE Healthcare Life Sciences, UT, USA). For induction of beige adipocyte
differentiation, beige adipogenesis inducing medium (BAIM), including 1 μM
dexamethasone, 0.5 mM isobutylmethylxanthine, 1 μM insulin, 125 μM indo-
methacin, and 1 nM triiodothyronine was used49. Cells were maintained at 37 °C in
incubator with 5% CO2. Cells were treated with isoproterenol (Sigma Aldrich,
USA) for 4 h after adipocyte differentiation.
Human adipocyte samples. Adipocyte RNA of subcutaneous abdominal adipose
tissues was obtained from 15 Saudi Arabian subjects. The local ethics committee of
the College of Medicine, King Saud University, approved experimental design and
adipose tissue samples collection (approval code 07-602). The procedures were
carried out in accordance with the approved protocol, with written informed
consent obtained from all subjects. Further information and requests for resources
and raw data should be directed, and will be fulﬁlled by the contact: A. A. Alfadda,
aalfadda@ksu.edu.sa.
Transfection. When the cells grow at the 70% of conﬂuence, cells were transfected
for 48 h with TonEBP siRNA or control scrambled siRNA (10 nM) and miR-
negative control, miR-30b or miR-30c (100 nM) using lipofectamine RNAiMAX
(Invitrogen, CA, USA) following the manufacturer’s instructions.
Isolation and differentiation of preadipocytes. Preadipocytes were isolated from
iWAT obtained from 4-week-old animals. iWAT was minced in DMEM/F12
medium and digested with 10 ml HEPES buffer containing 1 mg/ml type II col-
lagenase. They were incubated at 37 °C with gentle shaking for 1 h. After incuba-
tion, 10 ml of DMEM/F12 was added and they were centrifuged at 500 × g for 15
min. Stromal vascular cells (SVCs) were incubated with 5 ml of RBC lysis buffer
(Sigma Aldrich) for 5 min at room temperature and then they were ﬁltered with a
40 μm ﬁlter after addition of 10 ml of DMEM/F12. After centrifugation at 500 × g
for 5 min, SVCs were differentiated to beige adipocytes using BAIM.
Immunoblot assay. Cells were washed two times with cold PBS and lysed in RIPA
buffer (0.01 M Tris, pH 7.4, 0.15M NaCl, 0.001M EDTA, 0.001 M EGTA, 1%
Triton-X 100, 0.002M PMSF, and protease inhibitor (Roche, Rotkreuz, Switzer-
land)). After centrifugation of lysate, supernatant was used for immunoblot assay.
Protein concentration was measured by BCA protein assay system (Pierce Bio-
technology, IL, USA). Equal amounts of protein from each sample were separated
by SDS-PAGE. Anti-Adrb3 (Abcam, Cambridge, UK, #ab59685), anti-UCP-1
(EMD Milipore, CA, USA, #AB1426), anti-pAKT (Cell signaling, #9271 S), anti-
AKT (Cell signaling, #9272), anti-Hsc70 (Rockland, PA, USA, #200-301-A28), and
anti-TonEBP antibody5 were used for immunoblotting at 1:1000 dilution. HRP-
conjugated mouse, rabbit, or goat secondary antibodies were used for detection.
The antigen–antibody binding was detected by chemiluminescent detection reagent
(GE Healthcare, NJ, USA). Uncropped western blots are shown in Supplementary
Fig. 12.
RNA isolation and real-time PCR. Total RNA from human or mouse adipocytes,
mouse adipose tissues, or 3T3-L1 cells was isolated using the TRIzol reagent
(Invitrogen, CA, USA) according to the manufacturer’s instructions. cDNA was
synthesized by M-MLV reverse transcriptase (Promega, WI, USA). After reverse
transcription, real-time PCR was performed using SYBR Green I Master and
LightCycler 480 II (Roche). Measured cycle threshold values were normalized for
the cyclophilin A or 36B4 reference gene, and they were expressed as fold change
over control samples. Primers used are described in Supplementary Table 1.
Immunohistocytochemistry. Cells were grown on glass coverslips and ﬁxed with
4% paraformaldehyde in PBS (pH 7.4) for 20 min at 4 °C. Cells were permeabilized
with 0.3% Triton-X 100 in PBS for 30 min and blocked with PBS containing 3%
goat serum and 1% bovine serum albumin for 1 h at room temperature. After
incubation with rabbit anti-UCP-1 (EMD Millipore, #AB1426), Adrb3 (Abcam,
#ab59685), and rat anti-F4/80 (Abcam, #ab6640) at 1:100 dilution overnight at 4 °
C, the cells were washed with PBS and treated with goat anti-rabbit or anti-rat
Alexa Fluor 488-conjugated and Alexa Fluor 594-conjugated secondary antibodies
at 1:1000 dilution for 1 h. Cells were washed with PBS and incubated in 0.1 μg/ml
Hochest (DAPI) for 30 min. After washing with PBS, coverslips were mounted
onto microscope slides. Images were recorded using an Olympus FV1000 confocal
ﬂuorescence microscope.
Metabolic analysis. Fasting blood glucose, body weight, and food intake were
measured weekly, and body composition was measured using a quantitative
nuclear magnetic resonance system (EchoMRI100V; Echo Medical Systems, TX,
USA). Oxygen consumption, carbon dioxide production, heat production, and
locomotor activity were monitored using Comprehensive Lab Animal Monitoring
System (Columbus Instruments, OH, USA). Mice were given an oral injection of
D-glucose (2 g/kg body weight) after overnight starvation for the glucose tolerance
test and were intraperitoneally injected with insulin (0.75 U/kg body weight) for
insulin tolerance test. Serum glucose levels were determined in tail blood samples
using a glucometer. Body temperatures were measured using a digital thermometer
(TD-300; Shibaura Electronics, Tokyo, Japan).
Electromobility shift assay. Cells were harvested and centrifugation at 500 × g.
The cell pellet was washed by suspension with PBS. The cell nucleus and cytoplasm
were separated by using the Nuclear and Cytoplasmic extraction kit (Pierce),
according to the manufacturer’s instruction. Nuclear fraction was conﬁrmed by
Lamin B.
EMSA assay was performed using Lightshift Chemiluminescent EMSA kit
(Pierce). Five micrograms of nuclear extracts were incubated with poly(dI:dC),
binding buffer, and 5′ biotinylated DNA (5′-CAATTTGGAAAAATTTTGACT-3′
for TonEBP binding site on Adrb3 promoter) at room temperature for 20 min.
Samples were separated by electrophoresis for 4 h in 4% (40% 29:1 acrylamide/bis
solution) gel for TonEBP. The detection was performed according to the
manufacturer’s instructions.
Immunoprecipitation assay. Total cell lysates (10–500 μg) were prepared using
RIPA buffer in a tube on ice. Antibody (1–5 μg) was added to cell lysate and they
Fig. 5 DNMT suppresses WAT beiging and Adrb3 expression. a TonEBP, UCP-1 and Adrb3mRNA levels in 3T3-L1 adipocytes treated with 0–500 μM RG108
as indicated for 24 h (n= 4). b–e Animals were treated with vehicle or RG108 every 2 days from day −4 to 24. All animals were switched from CD to HFD
on day 0 (n= 5). Body weight (b), body composition by echo MRI (c), fat pad mass (iWAT and eWAT) (d), and fasting blood glucose levels (e) were
measured. f–k Animals were treated as above, except that the experiments were terminated on day 8 (n= 4). VO2 (f), VCO2 (g), heat production (h), and
rectal temperature (i) were measured. TonEBP, UCP-1, and Adrb3 mRNA (j) were measured, and H&E and immunostaining for UCP-1 and Adrb3 (k) were
performed from iWAT. Scale bars, 100 μm. l TonEBP, UCP-1, and Adrb3mRNA levels in 3T3-L1 adipocytes transfected with scr siRNA, DNMT1 (1), DNMT3a
(3a) or DNMT3b (3b) siRNA (n= 4). m 3T3-L1 adipocytes transfected with siRNA were transfected a second time with WT (left) or ΔTonE (right) Adrb3
promoter-luciferase reporter. Luciferase activity was measured (n= 4). n represents number of independent experiments with triplicate (a, l, m) or
biologically independent samples (b–j). All data are presented as mean+ s.d. (a, l, m) or s.e.m. (e, g–m). AU arbitrary unit. The p-values are determined by
unpaired t-test (c–e, j) or one-way ANOVA (a, b, f–i, l, m). *p < 0.05 vs. 0 (a), vehicle (b–j), or scr siRNA (l, m). Source data are provided as a Source
Data ﬁle
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were incubated for overnight at 4 °C under rotary agitation. Forty microliters of
protein A/G agarose beads (GE Healthcare) were added and incubated for 2 h at
4 °C under rotary agitation. The bead–antibody–antigen complex was spun down
by centrifugation at 4 °C for 1 min and removed the supernatant. The complex was
washed three times for 10 min by RIPA buffer at 4 °C. After washing, 40 μl of
sample buffer was added and boiled at 95 °C for 5 min. The samples were analyzed
by immunoblotting. Anti-DNMT1 (Abcam, #ab188453) and anti-TonEBP
antibody5 were used for immunoblotting at 1:1000 dilution. Uncropped western
blots of immunoprecipitated proteins are shown in Supplementary Fig. 13.
Chromatin immunoprecipitation assay. Cells were grown in 10-cm-diameter
culture dishes. Fixation was performed with 1% formaldehyde at room temperature
for 10 min. The ﬁxation was stopped with 0.125 M glycine for 5 min at room
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temperature. After three-times wash with cold PBS, cells were collected and lysed
in 1 ml of SDS lysis buffer (1% SDS, 10 mM EDTA and 50mM Tris-HCl pH 8.1)
for 10 min on ice. Cell lysates were sonicated (Bioruptor KRB-01, BMS, Tokyo,
Japan) for six cycles of 20 s on plus 30 s off with constant frequency and maximum
intensity to obtain DNA fragments between 400 and 1000 bp. Each sample was
diluted 1:10 with dilution buffer (0.01% SDS, 1.1% Triton-X 100, 1.2 mM EDTA,
16.7 mM Tris-HCl, pH 8.1, and 167 mM NaCl) for immunoprecipitation. Samples
were precleared with protein A Sepharose beads (Millipore, MA, USA) that were
previously pre-adsorbed with salmon sperm DNA for 1 h at 4 °C. Speciﬁc anti-
bodies were added after removing the preclearing beads: anti-PolII IgG (Abcam,
#ab817), anti-DNMT1 IgG (Abcam, #ab188453), anti-H3K4me1 IgG (Abcam,
#ab8895), anti-H3K4me3 (Abcam, #ab8580), anti-H3K27me3 (Abcam, #ab6002),
anti-H3K27ac (Abcam, #ab4729), anti-H3ac (EMD Millipore, #06–299), normal
rabbit IgG (Abcam, #ab171870), anti-TonEBP serum5, and normal rabbit serum
(Merck Millipore, Darmstadt, Germany). After adding antibodies (5 μl), the lysates
were incubated overnight at 4 °C. Protein A Sepharose beads were then added,
incubated for 2 h at 4 °C, and then washed with low salt washing buffer (0.1% SDS,
1% Triton-X 100, 20 mM Tris-HCl pH 8.1, 2 mM EDTA, and 10 mM NaCl), high
salt washing buffer (0.1% SDS, 1% Triton-X 100, 20 mM Tris-HCl, pH 8.1, 2 mM
EDTA, and 500 mM NaCl), LiCl washing buffer (0.25 M LiCl, 1% NP-40, 1%
deoxycholic acid, 1 mM EDTA, and 10 mM Tris-HCl, pH 8.1) and twice with ﬁnal
washing buffer (10 mM Tris-HCl, pH 8.0 and 1 mM EDTA). To elute the DNA,
beads were incubated with elution buffer (1% SDS and 100 mM NaHCO3) for 20
min at 65 °C. To reverse the cross-linking, samples were incubated overnight at 65 °
C in 200 mM NaCl, 30 min at 37 °C with 50 μg/ml RNase (Pierce) and 2 h at 45 °C
with 100 μg/ml proteinase K. DNA was puriﬁed using the PCR puriﬁcation kit
(Qiagen, CA, USA). DNA was then subjected to real-time PCR using primers: 5′-
GACAACTCATGGAGCAGTCTT-3′ and 5′-CTTACTTACTGTGCCATCT
CCC-3′ for the A region, 5′-GCCTTCCTTGTTGGGTAAAGGATA-3′ and 5′-
CAGCCTGGGCCATCTTCCCTAATTG-3′ for the B region, 5′-GAGGGGGAA
CCTTCCCACCCCA-3′ and 5′-AGTCCCACTACCAAGTCAGCTGCG-3′ for the
C region, and 5′-GGAGGAAGATGGAAACCAGAAG-3′ and 5′-CGCCACTATT
CCCAACTCTAAG-3′ for the D region of mouse Adrb3 promoter; 5′-GGGTTC
CTATAAATACGGACTGC-3′ and 5′-CTGGCACTGCACAAGAAGA-3′ for the
region of mouse GAPDH promoter. Immunoprecipitated DNA from each sample
was normalized to its respective chromatin input.
Luciferase assay. Cells were transfected with either a TonE-driven Photinus
luciferase or an adrb3 promoter 6kb-driven luciferase reporter vector (pGL3-
promoter vector, Promega). The Renilla luciferase reporter plasmid (pRL-TK,
Promega) was used as a control for transfection efﬁciency. To verify the binding of
miR-30b and miR-30c to the predicted sites in the 3-UTR region of the TonEBP
gene, predicting algorithms in Targetscan (www.targetscan.org) and psiCHECK-2
vector were used. A three-hundered base-pair region of the predicted miR-30b and
miR-30c binding sites in 3′-UTR of the TonEBP gene was cloned into a
psiCHECK-2 (Promega) downstream of the Renilla luciferase-coding region.
Luciferase activity was measured using the Dual-Luciferase Assay System (Pro-
mega) according to the manufacturer’s instructions. Luciferase activity was nor-
malized by activity of renilla luciferase.
ELISA and lipid analysis. Leptin and adiponectin in serum from mice were
analyzed by ELISA using a commercial kit (R&D Systems, MN, USA). Insulin was
analyzed by ELISA using a commercial kit (Alpco, NH, USA).
Triacylglycerol (TG), FFA, and cholesterol level in the serum were measured
using TG, FFA, or cholesterol quantiﬁcation kit (Abcam) according to the
manufacturer’s instructions.
MNase accessibility assay by real-time PCR. MNase accessibility assay by real-
time PCR was performed using MNase17. Washed cells were lysed in cold NP-
40 lysis buffer (10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 3 mM MgCl2, 0.5%
NP-40, 0.15 mM spermine (Sigma Aldrich), and 0.5 mM spermidine (Sigma
Aldrich)), followed by incubation on ice for 5 min. Nuclei were pelleted by
centrifugation at 2500 × g for 3 min at 4 °C and resuspended with MNase
digestion buffer without CaCl2 (10 mM Tris-HCl (pH 7.4), 15 mM NaCl, 60
mM KCl, 0.15 mM spermine, and 0.5 mM spermidine). After centrifugation,
the nuclei were resuspended with MNase digestion buffer supplemented with
CaCl2. Then, half of the each sample was treated MNase with 5 unit/sample
and the other half of that was treated digestion buffer, and samples were
incubated at 37 °C for 1 min. The digestion reaction was stopped by addition of
stop solution (100 mM EDTA/10 mM EGTA (pH 8.1) in 10 mM Tris-HCl (pH
7.4)). RNaseA (10 μg/sample) and proteinase K (100 μg/sample) were added
and samples were incubated at 37 °C overnight. DNA, puriﬁed by phenol/
chloroform/isoamyl alcohol extraction, was analyzed by real-time PCR using
primer pairs covering near −1.8-kb region of the Adrb3 promoter. Chromatin
accessibility was calculated from (amount of PCR product in undigested
sample)/(amount of PCR product in digested sample).
DNA methylation analysis using bisulﬁte sequencing. DNA was puriﬁed by
DNA puriﬁcation kit (Qiagen). Bisulﬁte conversion was performed using EpiTect
Bisulﬁte Kit (Qiagen). After conversion, Adrb3 promoter region of mouse or
human was ampliﬁed by real-time PCR using primers designed by Methprimer
software (www.urogene.org/methprimer/index1.html). Ampliﬁed DNA was cloned
into bacteria by TOPO TA cloning kit (Invitrogen). Plasmid from each clone was
sequenced by Macrogen commercial services (Daejeon, Korea).
Statistical analysis. Data are presented as means+ s.d. or+ s.e.m. Statistical
signiﬁcance (p < 0.05) was estimated by an unpaired t‐test for comparisons between
two conditions. A one‐way ANOVA was used for comparisons between more than
two conditions. Tukey’s post hoc test was used for multiple comparisons. All
statistics were performed with GraphPad Prism 5.0 software (GraphPad,
CA, USA).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the ﬁndings of this study are available from the corresponding authors
upon reasonable request. The source data underlying Figs. 1–6 are provided as a Source
Data ﬁle.
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